Jonathan R. Green - Concepedia

Author

Jonathan R. Green

Novartis (Switzerland)

Also Known As

JONATHAN R. GREEN, Jonathan R Green, Jonathan R. Green, Jonathan R. Green

Publications

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Novartis Institutes for BioMedical Research University of Liverpool University of Aberdeen

About

Jonathan R. Green is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.2K
2	Health Sciences	5	5	352
3	Natural Sciences	4	4	678
4	Biochemistry	4	4	289
5	Chemical Biology	1	1	222

Jonathan R. Green

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid Jeanette M. Wood, Karine Bonjean, Stephan Ruetz, Journal of Pharmacology and Experimental Therapeutics	2002	844
Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound Jonathan R. Green, Klaus Müller, Knut A. Jaeggi Journal of Bone and Mineral Research Bone ResorptionCgp 42'446ChemistryHeterocycle ChemistryOsteoporosis	1994	420
Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs Jean‐Michel Rondeau, Francis Bitsch, E. Bourgier, ChemMedChem Pharmaceutical ScienceMolecular BiologyVivo EfficacyPharmacotherapyChemical Biology	2006	222
Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen‐induced arthritis Natalie A. Sims, Jonathan R. Green, Markus Glatt, Arthritis & Rheumatism	2004	126
The bisphosphonate zoledronic acid has antimyeloma activity<i>in vivo</i>by inhibition of protein prenylation Andreas Guenther, Sharon Gordon, Markus Tiemann, International Journal of Cancer	2009	122
Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery Wolfgang Jahnke, Jean‐Michel Rondeau, Simona Cotesta, Nature Chemical Biology Medicinal ChemistryDrug TargetMedicineFragment-based DiscoveryRational Drug Design	2010	121
Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment A. Pataki, Klaus Müller, Jonathan R. Green, The Anatomical Record MechanobiologyBone DiseaseRat BoneHealth SciencesCancellous Bone Turnover	1997	114
Long-Term Protective Effects of Zoledronic Acid on Cancellous and Cortical Bone in the Ovariectomized Rat Jürg A. Gasser, Peter Ingold, Andrea Venturiere, Journal of Bone and Mineral Research	2007	102
Pharmacologic profile of zoledronic acid: A highly potent inhibitor of bone resorption Jonathan R. Green, Michael J. Rogers Drug Development Research Bone DiseaseZoledronic AcidBone HealthBone ResorptionOrthopaedic Surgery	2002	101
Renal Tolerability Profile of Novel, Potent Bisphosphonates in Two Short‐Term Rat Models Jonathan R. Green, Yves Seltenmeyer, Knut A. Jaeggi, Pharmacology & Toxicology Cgp 42446Bone ResorptionRenal InflammationPharmacotherapyOsteoporosis	1997	86

Page 1